- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 95,000 | 31.07.24 16:10:29 | -0,490 | -0,51% | 95,060 | 95,110 | 95,400 | 95,490 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 991,000 | 31.07.24 08:14:08 | +0,800 | +0,08% | 988,800 | 996,800 | 991,000 | 990,200 |
